“Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the pricing of its upsized public offering of 8,695,653 common shares at a public offering price of $5.75 per share, for gross proceeds of approximately $50...
* Click any company code in the table to access the share price, chart, announcements, registry details and dividend history * CodeCompanySectorMarket CapWeight(%) 14D 1414 Degrees Ltd Industrials 21,133,400 0.001 1ST 1ST Group Ltd Health Care 12,738,500 0.001 3PL 3P Learning Ltd Consumer ...
Across the ASX 101-200: Average and median cash pay also fell slightly (down 1.7% on last year on average). The report attributes the decline in part to the increased proportion of ASX101-200 CEOs receiving no cash bonus. The report comments that the decline in cash pay in FY19 for AS...
Access comprehensive information on the L1 Long Short Fund Limited (ASX:LSF), including share price, fund reports, performance & dividend reinvestment details
$0.680 $0.430 $0.047 $0.105 Closing share price USD $0.507 $0.494 $0.331 $0.033 $0.074 Loss per share (US cents) 1.24 1.22 1.76 0.95 1.64 Net tangible assets US cents per share 1.24 1.10 0.90 0.49 0.68 No dividends were issued in the past five years including the current financial year...